Publication | Open Access
CTPS1 promotes malignant progression of triple-negative breast cancer with transcriptional activation by YBX1
50
Citations
27
References
2022
Year
Our data demonstrate that YBX1/CTPS1 axis plays an important role in the progression of TNBC. CTPS1 might be a promising prognosis biomarker and potential therapeutic target for patients with triple-negative breast cancer.
| Year | Citations | |
|---|---|---|
Page 1
Page 1